| Dr Daniel Marcus Zeitler, MD | |
|
1100 9th Ave, Seattle, WA 98101-2756 | |
| (206) 223-6600 | |
| Not Available |
| Full Name | Dr Daniel Marcus Zeitler |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 20 Years |
| Location | 1100 9th Ave, Seattle, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154525012 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0901X | Otolaryngology - Otology & Neurotology | MD60546639 (Washington) | Primary |
| 207YX0901X | Otolaryngology - Otology & Neurotology | 50276 (Colorado) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Mason Medical Center | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Mason Medical Center | 9830002617 | 825 |
News Archive
The Prostate Cancer Foundation has presented Nima Sharifi, M.D., Kendrick Family Endowed Chair for Prostate Cancer Research at Cleveland Clinic's Lerner Research Institute, a Challenge Award to advance the treatment of lethal prostate cancer. He is also co-investigator on a second Challenge Award that was also selected for funding.
In the latest development as challenges to the health law work their way through the court system, a Pennsylvania judge struck down the individual mandate as well as provisions dealing with guaranteed issue and pre-existing conditions.
Researchers at The University of Texas at Austin have discovered that a type of cancer found primarily in children can grow only when signaled to do so by other nearby cells that are noncancerous.
In a study appearing in the May 3 issue of JAMA, Pascal Hammel, M.D., of Beaujon Hospital, Clichy, France and colleagues assessed whether chemoradiotherapy improves overall survival of patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine-based induction chemotherapy, and assessed the effect of erlotinib on survival. Gemcitabine and erlotinib are drugs used to treat cancer.
The earlier cancers can be detected, the better the chances of a cure. Researchers are now working to develop a new diagnostics platform with which the illness can be diagnosed in its early stages, even during a visit to the general practitioner: protein biomarkers in exhaled air divulge the presence of pathological cells in the lung.
› Verified 8 days ago
| Entity Name | Virginia Mason Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801851258 PECOS PAC ID: 9830002617 Enrollment ID: O20031107000383 |
News Archive
The Prostate Cancer Foundation has presented Nima Sharifi, M.D., Kendrick Family Endowed Chair for Prostate Cancer Research at Cleveland Clinic's Lerner Research Institute, a Challenge Award to advance the treatment of lethal prostate cancer. He is also co-investigator on a second Challenge Award that was also selected for funding.
In the latest development as challenges to the health law work their way through the court system, a Pennsylvania judge struck down the individual mandate as well as provisions dealing with guaranteed issue and pre-existing conditions.
Researchers at The University of Texas at Austin have discovered that a type of cancer found primarily in children can grow only when signaled to do so by other nearby cells that are noncancerous.
In a study appearing in the May 3 issue of JAMA, Pascal Hammel, M.D., of Beaujon Hospital, Clichy, France and colleagues assessed whether chemoradiotherapy improves overall survival of patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine-based induction chemotherapy, and assessed the effect of erlotinib on survival. Gemcitabine and erlotinib are drugs used to treat cancer.
The earlier cancers can be detected, the better the chances of a cure. Researchers are now working to develop a new diagnostics platform with which the illness can be diagnosed in its early stages, even during a visit to the general practitioner: protein biomarkers in exhaled air divulge the presence of pathological cells in the lung.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Marcus Zeitler, MD 1100 9th Ave, Seattle, WA 98101-2756 Ph: (206) 223-6600 | Dr Daniel Marcus Zeitler, MD 1100 9th Ave, Seattle, WA 98101-2756 Ph: (206) 223-6600 |
News Archive
The Prostate Cancer Foundation has presented Nima Sharifi, M.D., Kendrick Family Endowed Chair for Prostate Cancer Research at Cleveland Clinic's Lerner Research Institute, a Challenge Award to advance the treatment of lethal prostate cancer. He is also co-investigator on a second Challenge Award that was also selected for funding.
In the latest development as challenges to the health law work their way through the court system, a Pennsylvania judge struck down the individual mandate as well as provisions dealing with guaranteed issue and pre-existing conditions.
Researchers at The University of Texas at Austin have discovered that a type of cancer found primarily in children can grow only when signaled to do so by other nearby cells that are noncancerous.
In a study appearing in the May 3 issue of JAMA, Pascal Hammel, M.D., of Beaujon Hospital, Clichy, France and colleagues assessed whether chemoradiotherapy improves overall survival of patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine-based induction chemotherapy, and assessed the effect of erlotinib on survival. Gemcitabine and erlotinib are drugs used to treat cancer.
The earlier cancers can be detected, the better the chances of a cure. Researchers are now working to develop a new diagnostics platform with which the illness can be diagnosed in its early stages, even during a visit to the general practitioner: protein biomarkers in exhaled air divulge the presence of pathological cells in the lung.
› Verified 8 days ago
Judith A White, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1600 E Jefferson St, Suite 205, Seattle, WA 98122 Phone: 206-320-3900 Fax: 206-320-3899 | |
Kathleen Makielski, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 904 7th Ave, Seattle, WA 98104 Phone: 206-329-1760 | |
David Louis Horn, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Mailstop W-7729, Seattle, WA 98105 Phone: 206-987-2105 Fax: 206-987-3878 | |
Amit D Bhrany, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Bb1165, Box 356515, Seattle, WA 98195 Phone: 206-543-5230 Fax: 206-543-5152 | |
Gabriela Sanchez, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Broadway Ste 200, Seattle, WA 98122 Phone: 206-215-6009 Fax: 206-215-1771 | |
Sapna Ashok Patel, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Broadway Ste 280, Seattle, WA 98122 Phone: 206-386-3550 Fax: 206-386-3550 | |
John P Rowland, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 200 15th Ave E, Seattle, WA 98112 Phone: 206-326-3000 |